Inflammation associated anemia and ferritin as disease markers in SLE

Arthritis Research and Therapy

Volumn 14, Issue 4, 2012, Pages

  Vanarsa, Kamala ^a   Ye, Yujin ^a   Han, Jie ^a   Xie, Chun ^a   Mohan, Chandra ^a   Wu, Tianfu ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; FERRITIN; TRANSFERRIN;

ADULT; ANEMIA; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN MICROARRAY; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSFERRIN BLOOD LEVEL; URINE LEVEL; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; LUPUS ERYTHEMATOSUS, SYSTEMIC; PILOT STUDY; URINE; VALIDATION STUDY;

ADULT; ANEMIA; BIOLOGICAL MARKERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FERRITINS; HUMANS; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PILOT PROJECTS;

EID: 84864772018     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4012     Document Type: Article

References (31)

1. Uppal SS, Al-Mutairi M, Hayat S, Abraham M, Malaviya A. Ten years of clinical experience with adult onset Still's disease: is the outcome improving?. Clin Rheumatol 2007, 26:1055-1060. 10.1007/s10067-006-0440-x, 17086384.
2. Da Costa R, Szyper-Kravitz M, Szekanecz Z, Csepany T, Danko K, Shapira Y, Zandman-Goddard G, Orbach H, Agmon-Levin N, Shoenfeld Y. Ferritin and prolactin levels in multiple sclerosis. Isr Med Assoc J 2011, 13:91-95.
3. Blake DR, Bacon PA, Eastham EJ, Brigham K. Synovial fluid ferritin in rheumatoid arthritis. Br Med J 1980, 281:715-716. 10.1136/bmj.281.6242.715, 1713960, 7427414.
4. Muirden KD. Ferritin in synovial cells in patients with rheumatoid arthritis. Ann Rheum Dis 1966, 25:387-401. 2453468, 4161916.
5. Yildirim K, Karatay S, Melikoglu MA, Gureser G, Ugur M, Senel K. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis. Ann Clin Lab Sci 2004, 34:423-426.
6. Nishiya K, Hashimoto K. Elevation of serum ferritin levels as a marker for active systemic lupus erythematosus. Clin Exp Rheumatol 1997, 15:39-44.
7. Lim MK, Lee CK, Ju YS, Cho YS, Lee RS, Yoo B, Moon HB. Serum ferritin as a serologic marker of activity in systemic lupus erythematosus. Rheumatol Int 2001, 20:89-93. 10.1007/s002960000083, 11354563.
8. Beyan E, Beyan C, Demirezer A, Ertugrul E, Uzuner A. The relationship between serum ferritin levels and disease activity in systemic lupus erythematosus. Scand J Rheumatol 2003, 32:225-228. 10.1080/03009740310003712, 14626629.
9. Nishiya K, Kawabata F, Ota Z. Elevated urinary ferritin in lupus nephritis. J Rheumatol 1989, 16:1513-1514.
10. Theil EC. Ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms. Annu Rev Biochem 1987, 56:289-315. 10.1146/annurev.bi.56.070187.001445, 3304136.
11. Picard V, Epsztejn S, Santambrogio P, Cabantchik ZI, Beaumont C. Role of ferritin in the control of the labile iron pool in murine erythroleukemia cells. J Biol Chem 1998, 273:15382-15386. 10.1074/jbc.273.25.15382, 9624120.
12. Ferreira C, Bucchini D, Martin ME, Levi S, Arosio P, Grandchamp B, Beaumont C. Early embryonic lethality of H ferritin gene deletion in mice. J Biol Chem 2000, 275:3021-3024. 10.1074/jbc.275.5.3021, 10652280.
13. Chow JK, Werner BG, Ruthazer R, Snydman DR. Increased serum iron levels and infectious complications after liver transplantation. Clin Infect Dis 2010, 51:E16-E23. 10.1086/654802, 2897927, 20578876.
14. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood 2002, 99:3505-3516. 10.1182/blood.V99.10.3505, 11986201.
15. Torti SV, Kwak EL, Miller SC, Miller LL, Ringold GM, Myambo KB, Young AP, Torti FM. The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene. J Biol Chem 1988, 263:12638-12644.
16. Muntane-Relat J, Ourlin JC, Domergue J, Maurel P. Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology 1995, 22:1143-1153.
17. Rovin BH, Zhang X. Biomarkers for lupus nephritis: the quest continues. Clin J Am Soc Nephrol 2009, 4:1858-1865. 10.2215/CJN.03530509, 19729426.
18. Zandman-Goddard G, Orbach H, Agmon-Levin N, Boaz M, Amital H, Szekanecz Z, Szucs G, Rovensky J, Kiss E, Corocher N, Doria A, Stojanovich L, Ingegnoli F, Meroni PL, Rozman B, Gomez-Arbesu J, Blank M, Shoenfeld Y. Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients. Clin Rev Allergy Immunol 2011,
19. Zandman-Goddard G, Peeva E, Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev 2007, 6:366-372. 10.1016/j.autrev.2006.10.001, 17537382.
20. You SA, Wang Q. Ferritin in atherosclerosis. Clin Chim Acta 2005, 357:1-16. 10.1016/j.cccn.2005.02.001, 15963791.
21. Thomson AM, Rogers JT, Leedman PJ. Iron-regulatory proteins, iron-responsive elements and ferritin mRNA translation. Int J Biochem Cell Biol 1999, 31:1139-1152. 10.1016/S1357-2725(99)00080-1, 10582343.
22. Eisenstein RS. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu Rev Nutr 2000, 20:627-662. 10.1146/annurev.nutr.20.1.627, 10940348.
23. LaVaute T, Smith S, Cooperman S, Iwai K, Land W, Meyron-Holtz E, Drake SK, Miller G, Abu-Asab M, Tsokos M, Switzer R, Grinberg A, Love P, Tresser N, Rouault TA. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet 2001, 27:209-214. 10.1038/84859, 11175792.
24. Hirayama M, Kohgo Y, Kondo H, Shintani N, Fujikawa K, Sasaki K, Kato J, Niitsu Y. Regulation of iron metabolism in HepG2 cells: a possible role for cytokines in the hepatic deposition of iron. Hepatology 1993, 18:874-880. 10.1002/hep.1840180420, 8406363.
25. Weiss G, Goossen B, Doppler W, Fuchs D, Pantopoulos K, Werner-Felmayer G, Wachter H, Hentze MW. Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway. EMBO J 1993, 12:3651-3657. 413641, 7504627.
26. Carraway MS, Ghio AJ, Taylor JL, Piantadosi CA. Induction of ferritin and heme oxygenase-1 by endotoxin in the lung. Am J Physiol 1998, 275:L583-592.
27. Cohen LA, Gutierrez L, Weiss A, Leichtmann-Bardoogo Y, Zhang DL, Crooks DR, Sougrat R, Morgenstern A, Galy B, Hentze MW, Lazaro FJ, Rouault TA, Meyron-Holtz EG. Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood 2010, 116:1574-1584. 10.1182/blood-2009-11-253815, 20472835.
28. Morikawa K, Oseko F, Morikawa S. A role for ferritin in hematopoiesis and the immune system. Leuk Lymphoma 1995, 18:429-433. 10.3109/10428199509059641, 8528049.
29. Harada T, Baba M, Torii I, Morikawa S. Ferritin selectively suppresses delayed-type hypersensitivity responses at induction or effector phase. Cell Immunol 1987, 109:75-88. 10.1016/0008-8749(87)90293-0, 2958143.
30. Gray CP, Arosio P, Hersey P. Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells. Blood 2002, 99:3326-3334. 10.1182/blood.V99.9.3326, 11964300.
31. Baker JF, Ghio AJ. Iron homoeostasis in rheumatic disease. Rheumatology (Oxford) 2009, 48:1339-1344.